Update on Psilocybin and MDMA scheduling
Published
Related content
- Change to classification of psilocybin and MDMA to enable prescribing by authorised psychiatristsFrom 1 July this year, medicines containing the psychedelic substances psilocybin and MDMA can be prescribed by specifically authorised psychiatrists for the treatment of certain mental health conditions.
- Update on MDMA and psilocybin access and safeguards from 1 July 2023Stay updated about the commencement of MDMA and psilocybin for the treatment of certain mental illnesses.
- Proposal for the re-scheduling of Codeine productsThe Therapeutic Goods Administration has published an interim decision on a proposal to up-schedule codeine